Acetazolamide and Thyroid-Associated Ophthalmopathy; a Preliminary Tested Hypothesis in a TertiaryReferral Center
Open Access
- 1 January 2013
- journal article
- Vol. 2 (4) , 109-112
Abstract
This study evaluated the effect of acetazolamide on thyroid-associated ophthalmopathy (TAO). Patients with a VISA classification index equal to or more than four were enrolled in the study and were randomly assigned into two groups. In both groups, treatment was initiated using prednisolone. Patients in the case group received acetazolamide tablets 250 mg daily in addition to prednisolone. Three months later, the VISA inflammatory score of patients in both groups were determined. Subsequent to intervention with acetazolamide, the VISA inflammatory score of patients in the case group were reduced as follows; orbital pain (57.1% versus 41.7%, P=0.736), eyelid edema (42.8% versus 27.1%, P=0.67), chemosis (53.3% versus 33%, P=0.31), injection of the eyelids (60% versus 41.6%, P=0.342), and conjunctival injection (50% versus 46.13%, P=0.73). However, these reductions were not statistically significant when compared with those observed in the control group (P=0.246). In conclusion, the effect of acetazolamide on all the parameters of the VISA inflammatory score was examined independently. All patients in the case group revealed a reduction in VISA inflammatory score following intervention. However, these reductions were not statistically significant. Further studies with large sample sizes are required.Keywords
This publication has 8 references indexed in Scilit:
- VISA Classification for Graves OrbitopathyOphthalmic Plastic & Reconstructive Surgery, 2006
- Epidemiology and Prevention of Graves' OphthalmopathyThyroid®, 2002
- Thyrotropin Receptor Expression in Orbital Adipose/Connective Tissues from Patients with Thyroid-Associated OphthalmopathyThyroid®, 2002
- Orbital Fibroblasts Exhibit a Novel Pattern of Responses to Proinflammatory Cytokines: Potential Basis for the Pathogenesis of Thyroid-Associated OphthalmopathyThyroid®, 2002
- Clinical activity score as a guide in the management of patients with Graves' ophthalmopathyClinical Endocrinology, 1997
- Thyroid eye disease.British Journal of Ophthalmology, 1996
- Clinical criteria for the assessment of disease activity in Graves' ophthalmopathy: a novel approach.British Journal of Ophthalmology, 1989
- Case Report: Thyrotoxic Periodic Paralysis in a Latin-American Taking AcetazolamideThe American Journal of the Medical Sciences, 1989